Northern Trust Corp Cytosorbents Corp Transaction History

Northern Trust Corp

$658 Billion
Q1 2025

A detailed history of Northern Trust Corp transactions in Cytosorbents Corp stock. As of the latest transaction made, Northern Trust Corp holds 91,560 shares of CTSO stock, worth $107,125. This represents 0.0% of its overall portfolio holdings.

Number of Shares

91,560

Previous 91,560 -0.0%

Holding current value

$107,125

Previous $82,000 10.98%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$0.74 - $1.35 $12,358 - $22,546	16,701 Added 22.31%	91,560 $82,000
Q3 2024 Nov 13, 2024	SELL	$0.7 - $1.55 $1 - $3	-2 Reduced -0.0%	74,859 $112,000
Q2 2024 Aug 14, 2024	SELL	$0.7 - $1.01 $106 - $153	-152 Reduced 0.2%	74,861 $52,000
Q4 2023 Feb 13, 2024	SELL	$1.08 - $1.94 $2 - $3	-2 Reduced -0.0%	75,013 $83,000
Q2 2023 Aug 11, 2023	BUY	$2.37 - $3.65 $3,192 - $4,916	1,347 Added 1.83%	75,015 $269,000
Q1 2023 May 15, 2023	BUY	$1.79 - $4.17 $4,179 - $9,736	2,335 Added 3.27%	73,668 $248,000
Q3 2022 Nov 14, 2022	SELL	$1.2 - $2.46 $300 - $615	-250 Reduced 0.35%	71,333 $97,000
Q2 2022 Aug 12, 2022	SELL	$1.76 - $3.22 $511,827 - $936,411	-290,811 Reduced 80.25%	71,583 $157,000
Q1 2022 May 13, 2022	SELL	$2.88 - $4.23 $48,551 - $71,309	-16,858 Reduced 4.45%	362,394 $1.16 Million
Q4 2021 Feb 08, 2022	SELL	$4.05 - $8.11 $13,077 - $26,187	-3,229 Reduced 0.84%	379,252 $1.59 Million
Q3 2021 Nov 15, 2021	SELL	$7.0 - $9.71 $161,910 - $224,592	-23,130 Reduced 5.7%	382,481 $3.11 Million
Q2 2021 Aug 13, 2021	SELL	$7.55 - $9.42 $161,547 - $201,559	-21,397 Reduced 5.01%	405,611 $3.06 Million
Q1 2021 May 12, 2021	SELL	$8.23 - $11.48 $247,862 - $345,743	-30,117 Reduced 6.59%	427,008 $3.71 Million
Q4 2020 Feb 11, 2021	BUY	$7.65 - $8.98 $15,016 - $17,627	1,963 Added 0.43%	457,125 $3.64 Million
Q3 2020 Nov 16, 2020	BUY	$7.37 - $11.54 $706,760 - $1.11 Million	95,897 Added 26.69%	455,162 $3.63 Million
Q2 2020 Aug 14, 2020	BUY	$6.28 - $10.59 $65,085 - $109,754	10,364 Added 2.97%	359,265 $3.56 Million
Q1 2020 May 14, 2020	SELL	$3.77 - $7.73 $52,214 - $107,060	-13,850 Reduced 3.82%	348,901 $2.7 Million
Q4 2019 Feb 14, 2020	SELL	$3.61 - $5.22 $11,042 - $15,967	-3,059 Reduced 0.84%	362,751 $1.4 Million
Q3 2019 Nov 13, 2019	BUY	$4.33 - $7.63 $49,201 - $86,699	11,363 Added 3.21%	365,810 $1.84 Million
Q2 2019 Aug 13, 2019	BUY	$5.92 - $7.78 $34,643 - $45,528	5,852 Added 1.68%	354,447 $2.34 Million
Q1 2019 May 13, 2019	SELL	$6.82 - $8.56 $31,242 - $39,213	-4,581 Reduced 1.3%	348,595 $2.64 Million
Q4 2018 Feb 12, 2019	SELL	$7.05 - $12.64 $53,862 - $96,569	-7,640 Reduced 2.12%	353,176 $2.85 Million
Q3 2018 Nov 14, 2018	BUY	$10.95 - $14.8 $564,450 - $762,910	51,548 Added 16.67%	360,816 $4.66 Million
Q2 2018 Aug 14, 2018	BUY	$6.9 - $12.35 $1.8 Million - $3.23 Million	261,154 Added 542.78%	309,268 $3.53 Million
Q4 2017 Feb 14, 2018	SELL	$5.9 - $7.05 $3,840 - $4,589	-651 Reduced 1.33%	48,114 $313,000
Q3 2017 Nov 13, 2017	BUY	$4.5 - $6.2 $219,442 - $302,343	48,765	48,765 $302,000

Others Institutions Holding CTSO

# of Institutions

Shares Held

17.2M

Call Options Held

8.1K

Put Options Held

6.9K

View Full List

About Cytosorbents Corp

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $51M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

More about CTSO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Cytosorbents Corp Transaction History